Autor/in Burchert, A Kröger, N Ayuketang, Francis Ayuk 1 Bacher, U 1 Bader, P 1 Berg, T 1 Bug, G 1 Güller, S 1 Hildebrandt, Y 1 Hünecke, S 1 Klyuchnikov, E 1 Kropff, M 1 Metzelder, S K 1 Pflüger, K-H 1 Schetelig, J 1 Stübig, T 1 Wagner, E-M 1 Wolf, A 1 Wolschke, C 1 Zabelina, T 1 alle zeigenListe einklappen
Phase I/II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial) Bug, G Burchert, A Wagner, E-M Kröger, N Berg, T Güller, S Metzelder, S K 2017 - Forschungsinformationssystem des UKE
Toxicity-reduced, myeloablative allograft followed by lenalidomide maintenance as salvage therapy for refractory/relapsed myeloma patients. Kröger, N Zabelina, T Klyuchnikov, E Kropff, M Pflüger, K-H Burchert, A Stübig, T 2013 - Forschungsinformationssystem des UKE
